Home » Topics » Regulatory » Patents

Patents
RSS

Lilly's new orally active anticoagulants

Feb. 17, 1999

Vertex patents new series with strong and specific p38 kinase-inhibitory activity

Feb. 17, 1999

IL-1beta inhibitors from ADIR useful for inflammatory conditions

Feb. 16, 1999

Novel, orally bioavailable anticoagulants discovered at Lilly

Feb. 16, 1999

Astra discloses novel neuronal N-type calcium channel ligands

Feb. 16, 1999

New ribose-based antibacterial agents in development at HMR

Feb. 16, 1999

Imidazole cytokine-suppressive antiinflammatory compounds from SB

Feb. 16, 1999

U.S. university researchers claim anti-HIV 2',5'-phosphorothioate/phosphodiester oligoadenylates

Feb. 15, 1999

U. of Arizona prepares novel cyanoaziridine-based antitumor agents

Feb. 15, 1999

Na+/H+ antiport inhibitors in development at Synthelabo

Feb. 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...